Comerica Bank
ADPT icon

Comerica Bank’s Adaptive Biotechnologies ADPT Stock Holding History

Comerica Bank’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$32.9K Hold
2,024
– – ﹤0.01% 2983
2025
Q3 		$30.3K Hold
2,024
– – ﹤0.01% 2993
2025
Q2 		$23.6K Buy
+2,024
New +$18.4K ﹤0.01% 3008
2024
Q3 		– Sell
-13
Closed -$47 – 3672
2024
Q2 		$47 Sell
13
-2,920
-100% -$9.27K ﹤0.01% 3685
2024
Q1 		$9.41K Buy
2,933
+1,320
+82% +$5.11K ﹤0.01% 3192
2023
Q4 		$7.9K Buy
1,613
+1,039
+181% +$4.74K ﹤0.01% 3211
2023
Q3 		$3.13K Buy
+574
New +$3.8K ﹤0.01% 3483

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Comerica Bank's ADPT Position: Q4 2025 in Review

Comerica Bank held its Adaptive Biotechnologies (ADPT) position steady in Q4 2025 at 2,024 shares worth $32.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2983.

Comerica Bank first reported a position in ADPT in Q3 2023 and has held it in 7 quarters since. 283 funds tracked by Wall St. Rank hold ADPT as of Q4 2025.

  • Comerica Bank held 2,024 shares of Adaptive Biotechnologies worth $32.9K as of Q4 2025.
  • Comerica Bank left its Adaptive Biotechnologies share count unchanged in Q4 2025.
  • Adaptive Biotechnologies made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2983 holding.
  • Comerica Bank first reported a position in Adaptive Biotechnologies in Q3 2023 and has held it in 7 quarters since.
  • 283 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.